Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
Clinical trial NCT05753215 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05753215
- Sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-09
- Primary completion
- 2026-02-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.